HEADER HYDROLASE 23-JUL-15 5CS2 TITLE CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM DIADENOSINE TRIPHOSPHATE TITLE 2 HYDROLASE IN COMPLEX WITH CYCLOMARIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: HISTIDINE TRIAD PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: CYCLOMARIN A; COMPND 7 CHAIN: B SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM FALCIPARUM 3D7; SOURCE 3 ORGANISM_TAXID: 36329; SOURCE 4 STRAIN: ISOLATE 3D7; SOURCE 5 GENE: PF14_0349; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: T1 RESISTANT; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: STREPTOMYCES; SOURCE 11 ORGANISM_TAXID: 1883 KEYWDS CYCLOMARIN A, DIADENOSINE TRIPHOSPHATE HYDROLASE, ANTI-PLASMODIAL KEYWDS 2 ACTIVITY, MALARIA, PLASMODIUM FALCIPARUM, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR N.OSTERMANN,E.SCHMITT,B.GERHARTZ,A.HINNIGER,C.DELMAS REVDAT 5 20-NOV-24 5CS2 1 ATOM REVDAT 4 10-JAN-24 5CS2 1 SOURCE LINK ATOM REVDAT 3 15-MAY-19 5CS2 1 SEQRES REVDAT 2 27-JAN-16 5CS2 1 JRNL REVDAT 1 28-OCT-15 5CS2 0 JRNL AUTH N.BURSTNER,S.ROGGO,N.OSTERMANN,J.BLANK,C.DELMAS,F.FREULER, JRNL AUTH 2 B.GERHARTZ,A.HINNIGER,D.HOEPFNER,B.LIECHTY,M.MIHALIC, JRNL AUTH 3 J.MURPHY,D.PISTORIUS,M.ROTTMANN,J.R.THOMAS,M.SCHIRLE, JRNL AUTH 4 E.K.SCHMITT JRNL TITL GIFT FROM NATURE: CYCLOMARIN A KILLS MYCOBACTERIA AND JRNL TITL 2 MALARIA PARASITES BY DISTINCT MODES OF ACTION. JRNL REF CHEMBIOCHEM V. 16 2433 2015 JRNL REFN ESSN 1439-7633 JRNL PMID 26472355 JRNL DOI 10.1002/CBIC.201500472 REMARK 2 REMARK 2 RESOLUTION. 1.65 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 17.50 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 20891 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.195 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1044 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.65 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.74 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.49 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3034 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2398 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2883 REMARK 3 BIN R VALUE (WORKING SET) : 0.2377 REMARK 3 BIN FREE R VALUE : 0.2812 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.98 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 151 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1303 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 111 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 26.19 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.17580 REMARK 3 B22 (A**2) : -4.17580 REMARK 3 B33 (A**2) : 8.35170 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.238 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.104 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.099 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.099 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.096 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1339 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 1810 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 478 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 38 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 182 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1339 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 180 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1577 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.07 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.35 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.97 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5CS2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1000212098. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-NOV-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99997 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20919 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.650 REMARK 200 RESOLUTION RANGE LOW (A) : 17.500 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 200 DATA REDUNDANCY : 8.000 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.65 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : 0.75000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2FHI REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 27.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.71 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 UL OF PROTEIN-INHIBITOR SOLUTION REMARK 280 (11 MG/ML PFAP3AASE, 50 MM TRIS PH 8, 150 MM NACL, 5% GLYCEROL REMARK 280 AND 1 MM TCEP, 1MM CYCLOMARIN A) WAS MIXED WITH 0.2 UL RESERVOIR REMARK 280 SOLUTION (100 MM HEPES PH 7.5, 30% ISO-PROPANOL, 200 MM REMARK 280 MAGNESIUM CHLORIDE HEXAHYDRATE) AND EQUILIBRATED AGAINST 80 UL REMARK 280 RESERVOIR SOLUTION., VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 92.29333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 46.14667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 46.14667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 92.29333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 68.92950 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 -39.79647 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 PRO A 1 REMARK 465 TYR A 126 REMARK 465 LYS A 127 REMARK 465 ASN A 128 REMARK 465 ASN A 129 REMARK 465 ASP A 130 REMARK 465 ASN A 131 REMARK 465 ILE A 132 REMARK 465 TYR A 133 REMARK 465 ASN A 134 REMARK 465 ASP A 135 REMARK 465 MET A 136 REMARK 465 ASN A 137 REMARK 465 LYS A 138 REMARK 465 ILE A 139 REMARK 465 ASN A 140 REMARK 465 LEU A 141 REMARK 465 GLY A 142 REMARK 465 TYR A 143 REMARK 465 GLY A 144 REMARK 465 LYS A 145 REMARK 465 ASN A 146 REMARK 465 ILE A 147 REMARK 465 ILE A 148 REMARK 465 CYS A 149 REMARK 465 ASN A 150 REMARK 465 SER A 151 REMARK 465 CYS A 152 REMARK 465 ASN A 153 REMARK 465 ASN A 154 REMARK 465 THR A 155 REMARK 465 ILE A 156 REMARK 465 ASN A 157 REMARK 465 VAL A 158 REMARK 465 CYS A 159 REMARK 465 SER A 160 REMARK 465 GLN A 161 REMARK 465 ASN A 162 REMARK 465 GLU A 163 REMARK 465 ILE A 164 REMARK 465 GLU A 165 REMARK 465 ARG A 166 REMARK 465 ASN A 167 REMARK 465 PHE A 168 REMARK 465 LYS A 169 REMARK 465 LEU A 170 REMARK 465 GLU A 171 REMARK 465 GLU A 172 REMARK 465 PHE A 173 REMARK 465 ASN A 174 REMARK 465 THR A 175 REMARK 465 SER A 176 REMARK 465 SER A 200 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA B 3 -17.92 -144.52 REMARK 500 ALA B 3 -17.91 -144.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues 54C B 1 and WVL B 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues 54C B 1 and WLU B 2 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues WLU B 2 and WPA B 4 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues MLE B 6 and WVL B 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues MLE B 6 and WVL B 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues MLE B 6 and WVL B 7 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residues MLE B 6 and WVL B 7 DBREF 5CS2 A 2 200 UNP Q8IL97 Q8IL97_PLAF7 2 200 DBREF 5CS2 B 1 7 PDB 5CS2 5CS2 1 7 SEQADV 5CS2 GLY A 0 UNP Q8IL97 EXPRESSION TAG SEQADV 5CS2 PRO A 1 UNP Q8IL97 EXPRESSION TAG SEQRES 1 A 201 GLY PRO GLU LYS TYR LYS ASN ILE LEU GLU LYS LEU GLU SEQRES 2 A 201 TRP TYR LYS ASN LYS SER SER GLU LYS TYR GLU PHE GLY SEQRES 3 A 201 ILE TYR GLU ILE ASP LYS ARG GLU VAL PHE ILE THR THR SEQRES 4 A 201 LYS TYR SER TYR GLY PHE VAL ASN ASN LYS PRO LEU LEU SEQRES 5 A 201 PRO GLY HIS ILE LEU LEU THR THR LEU LYS LYS LYS LYS SEQRES 6 A 201 HIS TYR ASN ASP LEU ASP ILE GLU GLU ILE ILE ASP ILE SEQRES 7 A 201 ASN LEU LEU CYS ASN PHE MET CYS TYR ILE MET GLY ASN SEQRES 8 A 201 LEU PHE ASN THR THR ASP PHE SER ILE ALA ILE GLN ASP SEQRES 9 A 201 GLY LYS GLU ALA GLY GLN THR VAL ASP HIS VAL HIS ILE SEQRES 10 A 201 HIS ILE ILE PRO ARG LYS ILE ASN ASP TYR LYS ASN ASN SEQRES 11 A 201 ASP ASN ILE TYR ASN ASP MET ASN LYS ILE ASN LEU GLY SEQRES 12 A 201 TYR GLY LYS ASN ILE ILE CYS ASN SER CYS ASN ASN THR SEQRES 13 A 201 ILE ASN VAL CYS SER GLN ASN GLU ILE GLU ARG ASN PHE SEQRES 14 A 201 LYS LEU GLU GLU PHE ASN THR SER ILE ARG SER ILE GLU SEQRES 15 A 201 GLN MET GLU GLU GLU ALA ASN LEU ILE LYS SER TYR ILE SEQRES 16 A 201 ASN GLU LYS PHE SER SER SEQRES 1 B 7 54C WLU ALA WPA VAL MLE WVL HET 54C B 1 42 HET WLU B 2 20 HET WPA B 4 26 HET MLE B 6 18 HET WVL B 7 20 HET CL A1000 1 HETNAM 54C (BETAR)-BETA-HYDROXY-1-{2-[(2R)-OXIRAN-2-YL]PROPAN-2- HETNAM 2 54C YL}-L-TRYPTOPHAN HETNAM WLU (4R)-5-HYDROXY-N-METHYL-L-LEUCINE HETNAM WPA (BETAR)-BETA-METHOXY-L-PHENYLALANINE HETNAM MLE N-METHYLLEUCINE HETNAM WVL (2S,3R)-2-AMINO-3,5-DIMETHYLHEX-4-ENOIC ACID HETNAM CL CHLORIDE ION FORMUL 2 54C C16 H20 N2 O4 FORMUL 2 WLU C7 H15 N O3 FORMUL 2 WPA C10 H13 N O3 FORMUL 2 MLE C7 H15 N O2 FORMUL 2 WVL C8 H15 N O2 FORMUL 3 CL CL 1- FORMUL 4 HOH *111(H2 O) HELIX 1 AA1 GLU A 2 LEU A 11 1 10 HELIX 2 AA2 ASP A 30 ARG A 32 5 3 HELIX 3 AA3 HIS A 65 LEU A 69 5 5 HELIX 4 AA4 ASP A 70 ASN A 93 1 24 HELIX 5 AA5 GLY A 104 GLY A 108 5 5 HELIX 6 AA6 SER A 179 SER A 199 1 21 SHEET 1 AA1 2 GLU A 23 PHE A 24 0 SHEET 2 AA1 2 TYR A 27 GLU A 28 -1 O TYR A 27 N PHE A 24 SHEET 1 AA2 5 VAL A 34 THR A 37 0 SHEET 2 AA2 5 SER A 41 VAL A 45 -1 O GLY A 43 N ILE A 36 SHEET 3 AA2 5 ILE A 55 THR A 59 -1 O LEU A 56 N PHE A 44 SHEET 4 AA2 5 HIS A 115 ARG A 121 -1 O ILE A 116 N LEU A 57 SHEET 5 AA2 5 ASP A 96 ALA A 100 -1 N ALA A 100 O HIS A 117 LINK C A54C B 1 N AWLU B 2 1555 1555 1.37 LINK C B54C B 1 N BWLU B 2 1555 1555 1.37 LINK N A54C B 1 C AWVL B 7 1555 1555 1.35 LINK N B54C B 1 C BWVL B 7 1555 1555 1.35 LINK C AWLU B 2 N AALA B 3 1555 1555 1.35 LINK C BWLU B 2 N BALA B 3 1555 1555 1.35 LINK CG2AWLU B 2 CE2AWPA B 4 1555 4645 1.26 LINK CG2BWLU B 2 CE2BWPA B 4 1555 4645 1.26 LINK C AALA B 3 N AWPA B 4 1555 1555 1.36 LINK C BALA B 3 N BWPA B 4 1555 1555 1.36 LINK C AWPA B 4 N AVAL B 5 1555 1555 1.36 LINK C BWPA B 4 N BVAL B 5 1555 1555 1.36 LINK C AVAL B 5 N AMLE B 6 1555 1555 1.37 LINK C BVAL B 5 N BMLE B 6 1555 1555 1.37 LINK N AVAL B 5 C AWVL B 7 1555 4645 1.42 LINK N BVAL B 5 C BWVL B 7 1555 4645 1.42 LINK CA AVAL B 5 CA AWVL B 7 1555 4645 1.27 LINK CA AVAL B 5 CB AWVL B 7 1555 4645 1.31 LINK CA AVAL B 5 C AWVL B 7 1555 4645 1.45 LINK CA BVAL B 5 C BWVL B 7 1555 4645 1.45 LINK CA BVAL B 5 CA BWVL B 7 1555 4645 1.27 LINK CA BVAL B 5 CB BWVL B 7 1555 4645 1.31 LINK C AVAL B 5 C AWVL B 7 1555 4645 1.62 LINK C AVAL B 5 N AWVL B 7 1555 4645 1.26 LINK C BVAL B 5 C BWVL B 7 1555 4645 1.62 LINK C BVAL B 5 N BWVL B 7 1555 4645 1.26 LINK O AVAL B 5 CA AWVL B 7 1555 4645 1.33 LINK O AVAL B 5 C AWVL B 7 1555 4645 1.48 LINK O BVAL B 5 C BWVL B 7 1555 4645 1.49 LINK O BVAL B 5 CA BWVL B 7 1555 4645 1.33 LINK CB AVAL B 5 CG1AWVL B 7 1555 4645 1.18 LINK CB AVAL B 5 CD AWVL B 7 1555 4645 1.38 LINK CB BVAL B 5 CG1BWVL B 7 1555 4645 1.18 LINK CB BVAL B 5 CD BWVL B 7 1555 4645 1.38 LINK CG1AVAL B 5 CD AWVL B 7 1555 4645 1.59 LINK CG1BVAL B 5 CD BWVL B 7 1555 4645 1.59 LINK CG2AVAL B 5 CD AWVL B 7 1555 4645 1.15 LINK CG2BVAL B 5 CD BWVL B 7 1555 4645 1.15 LINK C AMLE B 6 N AWVL B 7 1555 1555 1.35 LINK C BMLE B 6 N BWVL B 7 1555 1555 1.35 LINK N AMLE B 6 CA AWVL B 7 1555 4645 1.56 LINK N AMLE B 6 N AWVL B 7 1555 4645 1.18 LINK N BMLE B 6 N BWVL B 7 1555 4645 1.18 LINK N BMLE B 6 CA BWVL B 7 1555 4645 1.56 LINK CB AMLE B 6 CG2AWVL B 7 1555 4645 1.52 LINK CB BMLE B 6 CG2BWVL B 7 1555 4645 1.52 CISPEP 1 54C B 1 WLU B 2 0 2.90 CISPEP 2 54C B 1 WLU B 2 0 2.94 CISPEP 3 VAL B 5 MLE B 6 0 3.03 CISPEP 4 VAL B 5 MLE B 6 0 3.10 SITE 1 AC1 3 GLY A 25 ILE A 26 ASP A 112 SITE 1 AC2 11 GLN A 102 GLU A 106 ALA A 107 GLY A 108 SITE 2 AC2 11 THR A 110 ARG A 121 WLU B 2 ALA B 3 SITE 3 AC2 11 WPA B 4 VAL B 5 MLE B 6 SITE 1 AC3 10 GLN A 102 GLU A 106 ALA A 107 GLY A 108 SITE 2 AC3 10 THR A 110 ARG A 121 ALA B 3 WPA B 4 SITE 3 AC3 10 VAL B 5 WVL B 7 SITE 1 AC4 5 54C B 1 ALA B 3 VAL B 5 MLE B 6 SITE 2 AC4 5 WVL B 7 SITE 1 AC5 7 HIS A 117 ARG A 121 HOH A1123 54C B 1 SITE 2 AC5 7 ALA B 3 WPA B 4 VAL B 5 SITE 1 AC6 7 HIS A 117 ARG A 121 HOH A1123 54C B 1 SITE 2 AC6 7 ALA B 3 WPA B 4 VAL B 5 SITE 1 AC7 7 HIS A 117 ARG A 121 HOH A1123 54C B 1 SITE 2 AC7 7 ALA B 3 WPA B 4 VAL B 5 SITE 1 AC8 7 HIS A 117 ARG A 121 HOH A1123 54C B 1 SITE 2 AC8 7 ALA B 3 WPA B 4 VAL B 5 CRYST1 45.953 45.953 138.440 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021761 0.012564 0.000000 0.00000 SCALE2 0.000000 0.025128 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007223 0.00000